1.
Acta Gastroenterol Belg
; 82(2): 319-321, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31314195
RESUMO
Olmesartan, an angiotensin receptor blocker, is a widely spread antihypertensive drug. Seronegative villous atrophy of the small intestine due to olmesartan use was first described in 2012. We present a new case of olmesartan-induced enteropathy and compare it to recent literature. This case might suggest a use of budesonide for treatment.